These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 403732)

  • 1. Antihaemophilic factor A activity, F VIII-related antigen and von Wilebrand factor in hepatic cirrhosis.
    Baele G; Matthijs E; Barbier F
    Acta Haematol; 1977; 57(5):290-7. PubMed ID: 403732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Factor VIII (coagulation activity VIII:C, antigen concentration VIIIR:Ag and von Willebrand factor) in patients with clinically expected intravascular coagulation].
    Tran TH; Lämmle B; Marbet UA; Ritz R; Marbet GA; Duckert F
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1542-3. PubMed ID: 6797063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between changes induced by venous occlusion on factor VIII-von Willebrand factor components and fibrinolytic activity.
    Ponari O; Pini M; Poli T; Poti R; Dettori AG
    Haemostasis; 1984; 14(2):179-83. PubMed ID: 6429015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophoretic heterogeneity of normal factor VIII/Von Willebrand protein, and abnormal electrophoretic mobility in patients with Von Willebrand's disease.
    Sultan Y; Simeon J; Caen JP
    J Lab Clin Med; 1976 Feb; 87(2):185-94. PubMed ID: 1082003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoradiometric assays for factor VIII antigens: coagulant protein (antihemophilic factor) and factor VIII-related protein (von Willebrand factor).
    Hoyer LW; Trabold NC
    Methods Enzymol; 1982; 84():51-60. PubMed ID: 6808318
    [No Abstract]   [Full Text] [Related]  

  • 6. Pathophysiology of von Willebrand's disease: Qualitative and quantitative analysis of von Willebrand protein.
    Fukui H; Yoshioka A; Mikami S; Takase T; Fujimura Y; Takahashi Y; Nishino M; Iwagaki K
    Nihon Ketsueki Gakkai Zasshi; 1979 Dec; 42(6):839-50. PubMed ID: 121660
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantitative and qualitative assessment of plasma von Willebrand factor variations, as induced by forearm venous stasis in patients with diabetic microangiopathy.
    Porta M; Ricchetti I; La Selva M; Bertagna A; Molinatti GM
    Diabetes Res; 1984 Nov; 1(4):219-21. PubMed ID: 6442228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor VIII-von Willebrand factor in giant cell arteritis and polymyalgia rheumatica.
    Persellin ST; Daniels TM; Rings LJ; Kazmier FJ; Bowie EJ; Hunder GG
    Mayo Clin Proc; 1985 Jul; 60(7):457-62. PubMed ID: 3925247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in renal failure.
    Warrell RP; Hultin MB; Coller BS
    Am J Med; 1979 Feb; 66(2):226-8. PubMed ID: 311586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of factor VIII related antigen as a means of demonstrating extramedullary haemopoiesis.
    Crocker J; Smith PJ
    J Clin Pathol; 1985 Mar; 38(3):355. PubMed ID: 3919067
    [No Abstract]   [Full Text] [Related]  

  • 11. Alterations of factor VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration.
    Lombardi R; Mannucci PM; Seghatchian MJ; Garcia VV; Coppola R
    Br J Haematol; 1981 Sep; 49(1):61-8. PubMed ID: 6791681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigations on the relationship of factor VIII related antigen, factor VIII procoagulant activity and Von Willebrand factor activity using insolubilized rabbit antiserum.
    Bouma BN; de Graaf S; Hordijk-Hos JM; van Mourik JA; Sixma JJ
    Thromb Res; 1975 Nov; 7(5):695-707. PubMed ID: 1082181
    [No Abstract]   [Full Text] [Related]  

  • 13. Von Willebrand Factor (VIIIVWF) in lyophilized Factor VIII concentrates.
    McCue MJ; Brossoit AD; Marmer DJ; Head DR
    Am J Hematol; 1980; 9(1):39-42. PubMed ID: 6776806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Stability of ristocetin cofactor and factor VIII associated antigen in relation to storage conditions].
    Töpfer G; Lutze G; Schmidt LH; Friedel G; Seifert A; Novy EM; Lehmann L
    Z Med Lab Diagn; 1983; 24(8):463-8. PubMed ID: 6424351
    [No Abstract]   [Full Text] [Related]  

  • 15. Factor VIII-related antigen levels in normal pregnancy and puerperium.
    Chan SY; Chan PH; Ho PC; Yam A
    Eur J Obstet Gynecol Reprod Biol; 1985 Apr; 19(4):199-204. PubMed ID: 3924674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudo-von Willebrand's disease.
    Hoyer LW
    N Engl J Med; 1982 Feb; 306(6):360-2. PubMed ID: 6798443
    [No Abstract]   [Full Text] [Related]  

  • 17. Modification of factor VIII complex properties in patients with liver disease.
    Maisonneuve P; Sultan Y
    J Clin Pathol; 1977 Mar; 30(3):221-7. PubMed ID: 300380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
    Ruggeri ZM; Zimmerman TS
    J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of von Willebrand factor, factor VIII related antigen and factor VIII coagulant response to human growth hormone infusion in type 2 diabetes mellitus.
    Grecu EO; Sheikholislam BM; Abildgaard CF
    Am J Med Sci; 1984; 287(2):3-6. PubMed ID: 6424471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sugar-chain of factor VIII/von Willebrand factor in von Willebrand's disease. Analysis by immuno-affinoelectrophoresis using lectin].
    Ueda M; Yasui M; Nishino M; Mikami S; Fukui H
    Nihon Ketsueki Gakkai Zasshi; 1983 Sep; 46(5):1117-23. PubMed ID: 6421045
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.